-- Park Assumes Role of President and General Manager of inVentiv Health Korea, Helping Life Science Companies Navigate the Complex Asian Marketplace
BURLINGTON, Massachusetts, June 30, 2014 /PRNewswire/ -- inVentiv Health, Inc., a life science knowledge and service company, announced today the appointment of an industry veteran with deep expertise in the Asian pharmaceutical marketplace to lead the office in Seoul, Korea.
Kihwan Park assumes the role of President and General Manager of inVentiv Health Korea, bringing broad management expertise and decades of experience in building great teams to his new role. He will report to Dan Feldman, President of inVentiv Health Asia.
Park served most recently as Managing Director of UCB China and South East Asia, where he spearheaded the design and implementation of UCB's growth strategies. Before being assigned to China, he led UCB Korea, making it one of Korea's most effective and efficient pharmaceutical companies.
"Kihwan is recognized throughout the industry for his ability to enact big picture strategies while developing strong, ongoing business results," Feldman said. "With his excellent leadership and team building skills, as well as his ability to attract, develop and retain top talent, he will assure the Korean office provides pharmaceutical clients with the best commercial and clinical services available anywhere in Asia."
Park also has worked in Korea for AstraZeneca as the Business Unit Head for its GI, Respiratory and CNS franchises. Previously, he worked for a decade with major pharmaceutical companies in the United States, including Eli Lilly as a corporate MBA hire, then Bristol-Myers Squibb Company as Director of International Marketing and Elan Corp. as Senior Director for Global Marketing.
Park received his MBA from New York University's Stern School of Business, and his BA from Yonsei University in Seoul.
About inVentiv Health
inVentiv Health, Inc. is a life science knowledge and services company purpose-built for the new healthcare marketplace. inVentiv has created a new model by converging a vast range of essential services to fully align with our clients' development and commercialization goals. With more than 12,000 employees supporting clients in 70 countries, our global scale and broad expertise make us an attractive strategic partner for companies seeking to get medicines to patients in a complex operating, regulatory and reimbursement environment. inVentiv Health's clients include more than 550 life sciences companies, including all 20 of the largest biopharmaceutical companies in the world. inVentiv Health, Inc. is privately owned by inVentiv Group Holdings, Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. inVentiv Health transforms promising ideas into commercial reality for the financial success of our clients and the delivery of better treatments to patients worldwide. For more information, visit www.inVentivHealth.com.
inVentiv Health, Inc.